Research team found that by using precursor cells that had not completely differentiated, the transplanted cells could regenerate into fully functional beta cells.
Scientists Identify a Critical Molecule That Helps Explain Why Diabetics Suffer from Non-Healing Wounds
Scientists have identified a critical molecule that helps explain why diabetics suffer from non-healing wounds and pinpoint a target for therapies that could help boost healing.
A natural, non-toxic byproduct of glucose may prevent brain cell death and cognitive impairment in diabetics following an episode of severely low blood sugar.
Scientists report that transplanted insulin-producing cells survive better when the activation of a specific type of immune cell is blocked.
A new method that uses nanotechnology to rapidly measure minute amounts of insulin is a major step toward developing the ability to assess the health of the body's insulin-producing cells in real time.
About one-third of type 1 diabetics (T1D) produce insulin even upward of forty years from initial diagnosis, according to a new study.
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.
An older type of long-acting insulin is as effective in treating type 2 diabetes as newer and more expensive kinds. However, the newer medications may cause fewer problems with low blood glucose while patients are sleeping.
Researchers have identified a key molecular pathway responsible for the natural decrease in the proliferation of insulin-producing cells that occurs as a person ages. Artificially activating this pathway, which is normally not functional in adults, may be a new way to combat diabetes.
Researchers have discovered a hormone pathway that potentially could lead to new ways of treating type 1 diabetes independent of insulin.
Patients with type 1 diabetes have an improved prognosis with regard to end-stage renal disease over the past four decades.
Patients with type 1 diabetes who received islet transplantation from a single donor pancreas were insulin independent one year later, according to a recent study.
FDA has cleared the first over-the-counter test that measures glycated hemoglobin in people with diabetes.
Joslin study shows durability of insulin pump therapy for adolescents and identifies factors to help them overcome barriers to success.
Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease.
Type 1 diabetics who have developed low blood sugar (hypoglycemia) as a complication of insulin treatments over time are able to regain normal internal recognition of the condition after receiving pancreatic islet cell transplantation.